Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/19/2010US7816337 Drug delivery; to decrease cellular toxicity and improve efficacy
10/19/2010US7816336 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010US7816321 treating skin lesions, heart injuries, corneal lesions and/or coronary heart disease
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816140 Composition and methods for osteogenic gene therapy
10/19/2010US7816139 transformed plant cell comprising a transgene that comprises a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 159 or SEQ ID NO: 171; REVOLUTA
10/19/2010US7816136 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy; supporters being genetically modified in order to provide externally regulatable interactions between the supporters and the stem cells; supporters and stem cells are interchangeable upon modification
10/19/2010US7816132 DNA encoding plexin polypeptides and kits thereof
10/19/2010US7816131 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain
10/19/2010US7816130 Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences
10/19/2010US7816129 Production and secretion of proteins of bacterial origin in filamentous fungi
10/19/2010US7816116 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine
10/19/2010US7816115 Subtilases
10/19/2010US7816111 Enhanced heat resistant glucose dehydrogenase for coupling to oxido- or reductase enzymes to produce synthetic organic chemicals or precursors
10/19/2010US7816108 producing ethanol by providing a polypeptide having alpha-amylase activity, contacting a starch-comprising composition with the polypeptide to produce a sugar, and fermenting the sugar to produce ethanol
10/19/2010US7816104 Packaging cells for recombinant adenovirus
10/19/2010US7816103 Protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid; for treating cartilage and bone diseases
10/19/2010US7816098 Forming protein array for screening; generating antibodies
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7816093 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
10/19/2010US7816086 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/19/2010US7816085 generating a polynucleotide sequence or population of sequences from parent single stranded polynucleotide sequences encoding one or more protein motifs; amplification
10/19/2010US7816075 treating a human afflicted with condition characterized by elevated serum triglyceride or very low density lipoprotein (VLDL), comprising the step of administering an inhibitor of human delta-9 stearoyl-CoA desaturase (SCD1) activity; coronary artery disease, Type II diabetes, obesity
10/19/2010US7815941 Nucleic acid microspheres, production and delivery thereof
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815902 Methods and compositions for cancer therapy using a novel adenovirus
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010CA2495298C Use of antisense oligonucleotides to inhibit the expression of akt-1
10/19/2010CA2494570C Seed-specific gene promoters and uses thereof
10/19/2010CA2437145C Peptide or protein microassay method and apparatus
10/19/2010CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
10/19/2010CA2430661C Purified active hcv ns2/3 protease
10/19/2010CA2429544C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
10/19/2010CA2429451C Isolated luciferases and their use
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2422956C Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
10/19/2010CA2420159C Model animal for type iii allergy inflammation
10/19/2010CA2407270C Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method
10/19/2010CA2400667C Modified nodavirus rna for gene delivery
10/19/2010CA2397789C Novel human kinase protein and polynucleotides encoding the same
10/19/2010CA2397527C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2385287C Signal sequences for preparing leu-hirudin by secretion by e. coli into the culture medium
10/19/2010CA2384313C Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2380395C Conditional-selex
10/19/2010CA2365020C Ganp proteins
10/19/2010CA2351233C Production of exopolysaccharides unattached to the surface of bacterial cells
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2307842C Hyaluronan synthase gene and uses thereof
10/19/2010CA2298412C Identification of human cell lines for the production of human proteins by endogenous gene activation
10/19/2010CA2296704C Cardiac muscle regeneration using mesenchymal stem cells
10/19/2010CA2289091C Single zymomonas mobilis strain for xylose and arabinose fermentation
10/19/2010CA2218251C Coding sequences of the human brca1 gene
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/19/2010CA2103248C Novel bacillus thuringiensis isolates active against hymenopteran pests and genes encoding hymenopteran-active toxins
10/16/2010CA2749063A1 High yielding, soybean cyst nematode and phytophthora resistant soybean variety 92y53
10/14/2010WO2010118404A2 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
10/14/2010WO2010118360A1 Production of proteins using transposon-based vectors
10/14/2010WO2010118338A2 Plant snf1-related protein kinase gene
10/14/2010WO2010118337A2 Methods of enhancing yield of active iga protease
10/14/2010WO2010118263A1 Single-nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
10/14/2010WO2010118244A1 Alphavirus Replicon Particles Expressing TRP2
10/14/2010WO2010118240A1 A genetically stable plasmid expressing pdh and fdh enzymes
10/14/2010WO2010118224A1 Preventing islet inflammation and dysfunction and maintaining proper glucose levels by controlling elf5a and its hypusination
10/14/2010WO2010118205A2 Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
10/14/2010WO2010118203A2 Endosialin binding molecules
10/14/2010WO2010118188A2 Production of an intact virus in a non-host cell system using a secondary host viral construct
10/14/2010WO2010118093A2 Screening for environmental dnas encoding enzymes for synthesizing terpenoid-based therapeutic compounds using genetically modified e. coli strains
10/14/2010WO2010118077A1 Nanoparticle mediated delivery of sequence specific nucleases
10/14/2010WO2010118058A2 Polypeptides having cellulase activity
10/14/2010WO2010118045A1 Transcriptome transfer produces cellular phenotype conversion
10/14/2010WO2010118016A2 Digital quantification of dna methylation
10/14/2010WO2010118007A2 Enhanced cellulase expression in s. degradans
10/14/2010WO2010117978A1 Peptides for stimulating plant disease resistance
10/14/2010WO2010117860A2 Microrna signature to predict prognosis in heart failure
10/14/2010WO2010117843A2 Termite enzymes and uses thereof for in vitro conversion of lignin-containing materials to fermentable products
10/14/2010WO2010117829A2 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
10/14/2010WO2010117817A2 Methods for generating target specific probes for solution based capture
10/14/2010WO2010117804A2 Mostly natural dna sequencing by synthesis
10/14/2010WO2010117750A2 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle
10/14/2010WO2010117620A2 Gene expression analysis in single cells
10/14/2010WO2010117465A2 Uses for long polar fimbriae genes of pathogenic escherichia coli strains
10/14/2010WO2010117464A1 Targeted integration into stem cells
10/14/2010WO2010117071A1 Ubiquitin fusion gene, and dna vaccine using same
10/14/2010WO2010117057A1 Method for treatment of blood tumor using anti-tim-3 antibody
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010117010A1 Tumor marker and use thereof
10/14/2010WO2010116926A1 Tumor-specific promoter and use thereof
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
1 ... 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 ... 4023